Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)

NCT06909565 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06909565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06909565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Recruiting
Start date
July 23, 2025
Completion date
December 31, 2029
Enrollment
6,000 (estimated)
Sites
142

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention, peripheral endovascular intervention